Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 433

    1.

    Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

    Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC.

    Ann Intern Med. 2008 Feb 19;148(4):284-94. Erratum in: Ann Intern Med. 2008 Aug 5;149(3):219. PMID: 18283206 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Acetylcysteine for prevention of contrast nephropathy: meta-analysis.

    Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude FJ, Braun C.

    Lancet. 2003 Aug 23;362(9384):598-603.PMID: 12944058 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Contrast induced nephropathy]

    Hörl WH.

    Wien Klin Wochenschr. 2009;121(1-2):15-32. Review. German. PMID: 19263010 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine]

    Gawenda M, Möller A, Wassmer G, Brunkwall J.

    Zentralbl Chir. 2007 Jun;132(3):227-31. German. PMID: 17610195 [PubMed - indexed for MEDLINE]Related articles

    5.

    Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.

    Misra D, Leibowitz K, Gowda RM, Shapiro M, Khan IA.

    Clin Cardiol. 2004 Nov;27(11):607-10.PMID: 15562929 [PubMed - indexed for MEDLINE]Related articles

    6.

    Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

    Bagshaw SM, Ghali WA.

    Arch Intern Med. 2005 May 23;165(10):1087-93. Review.PMID: 15911721 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis.

    Liu R, Nair D, Ix J, Moore DH, Bent S.

    J Gen Intern Med. 2005 Feb;20(2):193-200. Review.PMID: 15836554 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

    Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR.

    Am J Kidney Dis. 2009 Apr;53(4):617-27. Epub 2008 Nov 22. Review.PMID: 19027212 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.

    Huber W, Eckel F, Hennig M, Rosenbrock H, Wacker A, Saur D, Sennefelder A, Hennico R, Schenk C, Meining A, Schmelz R, Fritsch R, Weiss W, Hamar P, Heemann U, Schmid RM.

    Radiology. 2006 Jun;239(3):793-804.PMID: 16714461 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.

    Duong MH, MacKenzie TA, Malenka DJ.

    Catheter Cardiovasc Interv. 2005 Apr;64(4):471-9. Review.PMID: 15789388 [PubMed - indexed for MEDLINE]Related articles

    11.

    Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.

    Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER.

    Am J Med. 2004 Dec 15;117(12):938-47.PMID: 15629733 [PubMed - indexed for MEDLINE]Related articles

    12.

    Recent advances in the prevention of radiocontrast-induced nephropathy.

    Marenzi G, Bartorelli AL.

    Curr Opin Crit Care. 2004 Dec;10(6):505-9. Review.PMID: 15616393 [PubMed - indexed for MEDLINE]Related articles

    13.

    Systematic review of the impact of N-acetylcysteine on contrast nephropathy.

    Pannu N, Manns B, Lee H, Tonelli M.

    Kidney Int. 2004 Apr;65(4):1366-74. Review.PMID: 15086476 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prevention of contrast nephropathy in critically ill patients using acetylcysteine and theophylline.

    Mueller C.

    Int J Artif Organs. 2004 Dec;27(12):1066-9. Review.PMID: 15645617 [PubMed - indexed for MEDLINE]Related articles

    16.

    N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.

    Zagler A, Azadpour M, Mercado C, Hennekens CH.

    Am Heart J. 2006 Jan;151(1):140-5.PMID: 16368307 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prevention of contrast-induced nephropathy: a critical review.

    Van Praet JT, De Vriese AS.

    Curr Opin Nephrol Hypertens. 2007 Jul;16(4):336-47. Review.PMID: 17565276 [PubMed - indexed for MEDLINE]Related articles

    18.

    Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.

    Pannu N, Tonelli M.

    Curr Opin Nephrol Hypertens. 2006 May;15(3):285-90. Review.PMID: 16609296 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prophylaxis strategies for contrast-induced nephropathy.

    Pannu N, Wiebe N, Tonelli M; Alberta Kidney Disease Network.

    JAMA. 2006 Jun 21;295(23):2765-79. Review.PMID: 16788132 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.

    Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Magnus Ohman E, Finn WF.

    J Am Soc Nephrol. 2004 Mar;15(3):761-9. Review.PMID: 14978179 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data